SEPTInvestingStart Free

CGEM SCHEDULE 13G: SEC filing

State Street Corporation

Filed with the SEC on · accession 0000093751-26-000639

CGEM filed a SCHEDULE 13G (schedule 13g) with the SEC on Nov 10, 2026. State Street Corporation filed a Schedule 13G disclosing beneficial ownership of 2,604,105 shares of Cullinan Therapeutics, Inc. common stock, representing approximately 4.0% of the class. The stock moved -4.8% by the first close after the filing.

Summary of the filing

State Street Corporation filed a Schedule 13G disclosing beneficial ownership of 2,604,105 shares of Cullinan Therapeutics, Inc. common stock, representing approximately 4.0% of the class. The filing is a passive institutional ownership disclosure under Rule 13d-1(b).

For details, click here →

Key details

Shares beneficially owned$2.6M
Shares with sole voting power$2.5M
Filer / beneficial ownerState Street Corporation
Subject company / issuerCullinan Therapeutics, Inc.
Senior vice president, state street corporationAlok Maheshwary

How CGEM stock reacted

Close before

$11.73

Nov 9, 2026

First close after

-4.77%

$11.17

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for CGEM, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for CGEM?

Click here

Frequently asked questions

What did CGEM file with the SEC on Nov 10, 2026?

CGEM filed a SCHEDULE 13G (SEC filing). State Street Corporation filed a Schedule 13G disclosing beneficial ownership of 2,604,105 shares of Cullinan Therapeutics, Inc. common stock, representing approximately 4.0% of the class. The filing is a passive institutional ownership disclosure under Rule 13d-1(b).

How do I read a SCHEDULE 13G?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G (schedule 13g): A report the company filed with the SEC (the US market regulator).

How did CGEM stock react to this filing?

CGEM closed at $11.73 before the filing and $11.17 on Nov 10, 2026 (-4.77%).

Other CGEM SEC filings

Get alerts when CGEM files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days
CGEM overviewCGEM analysisCGEM newsLatest SEC filings